• Home
  •  
    Regions
    • Europe
    • UK & Ireland
    • DACH
    • Nordic
    • France
    • Southern Europe
    • Benelux
    • CEE
    • Asia
  •  
    Deals
    • Buyouts
    • Venture
    • Exits
    • Refinancings
    • Build-up
    • Turnaround
    • Secondaries
    • Advanced deals search
  •  
    Funds
    • Buyout
    • Venture
    • Mezzanine
    • Debt
    • Funds-of-funds
    • Secondaries
    • Fundraising pipelines
    • Advanced funds search
  •  
    GPs & LPs
    • GP profiles
    • LP profiles
    • GP news
    • LP news
    • Sponsors search
    • LPs search
  •  
    Secondaries
    • Deals
    • Funds
    • News
    • Analysis
  •  
    People
    • People moves
    • Analysis
    • In Profile
    • Q&A
    • Videos
    • Comment
  •  
    Analysis
    • In Profile
    • Fundraising
    • Q&A
    • Comment
    • Videos
    • Podcast
    • Reports
    • Data Snapshots
  •  
    Unquote Data
    • Deals search
    • Exits search
    • Funds search
    • Sponsors search
    • Advisers search
    • LPs search
    • League tables
    • Reports
  • Sign in
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)203 741 1137

      Email: Georgina.Lawson@acuris.com

      • Sign in
     
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • Twitter
    • LinkedIn
  • Free Trial
  • Subscribe
Unquote
Unquote
  • Home
  • Regions
  • Deals
  • Funds
  • GPs & LPs
  • Secondaries
  • People
  • Analysis
  • Unquote Data
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)203 741 1137

    Email: Georgina.Lawson@acuris.com

    • Sign in
 
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 
Unquote
  • Buyouts

Astorg acquires surgery supplies manufacturer Demetra

  • Greg Gille
  • Greg Gille
  • @unquotenews
  • 06 August 2021
  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  

Astorg has invested in Demetra, an Italian manufacturer of surgical devices, while minority backer Keensight has exited the business.

French buyout house Keensight merged medical technology businesses Tecres and Aap Biomaterials into Demetra Holding in 2016. Prior to the transaction, Keensight fully bought Aap Biomaterials from parent company Aap Implantate for EUR 36.6m, according to press reports at the time. Keensight then invested an undisclosed amount in the newco, Demetra Holding, alongside Tecres's shareholders, with the latter retaining a controlling stake in the group.

Keensight said that the company tripled revenues during its ownership. It also expanded internationally, especially in the US and in Asia, where Demetra signed new joint ventures and opened new production sites.

Demetra

  • DEAL:

    SBO

  • LOCATION:

    Milan

  • SECTOR:

    Medical equipment

  • FOUNDED:

    2016

  • VENDOR:

    Keensight

Astorg is currently deploying equity via the latest vehicle in its flagship strategy, Astorg VII, which held a final close in January 2019 on EUR 4bn. The fund targets B2B businesses with enterprise values of more than EUR 200m and deploys equity tickets of EUR 100m-400m.

Astorg has had a busy 2021 on the buy-side so far. It recently teamed up with Bridgepoint to buy Irish financial software company Fenergo from Insight Partners. According to the Irish Times, Bridgepoint and Astorg jointly acquired a majority stake for USD 600m in a deal valuing the business at USD 1.165bn.

Astorg also bought French food ingredients producer Solina from Ardian; according to local publication L'Agefi, the deal valued the company at around EUR 1.7bn.

Earlier this year, Astorg VII entered exclusive negotiations to acquire CVC's aluminium systems business Corialis for a reported EUR 1.6bn-1.7bn. It also bought UK-based data automation software developer Xceptor from CBPE; Astorg clinched the asset with a bid in the region of GBP 430m, equating to roughly 30x the company's EBITDA of GBP 14m, two sources familiar with the situation told Mergermarket at the time. Astorg's bid was financed entirely in equity, the report added.

The GP is preparing the launch of its next flagship fund, as reported. It is also fundraising for its Mid-Cap Fund, with the process expected to be finalised this summer.

Company
Created in 2016 following the combination of Italy-based Tecres and Germany-based Osartis, Demetra develops, manufactures and distributes products used in orthopaedic implant surgeries and spine interventions. It employs 200 staff.

The group notably develops bone cement, a product used for the fixation of orthopaedic implants and for the filling of vertebral compression fractures. It also offers preformed spacers, which are ready-to-use, antibiotic-loaded temporary implants used to treat local infections that can occur for patients who have had implant surgery.

The two businesses continue to operate under their respective brands.

People
Astorg – Lorenzo Zamboni (partner).
Keensight - Pierre Rémy (managing partner).

Advisers
Vendors – Rothschild & Co (M&A); Gattai Minoli Partners (legal).
Equity – BonelliErede (legal); EY (financial due diligence).

  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  
  • Topics
  • Buyouts
  • Southern Europe
  • DACH
  • Healthcare
  • Exits
  • Astorg Partners
  • Keensight Capital
  • Secondary buyout
  • Rothschild

More on Buyouts

Clinical trials and biotechnology
Permira to take Ergomed private for GBP 703m

Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO

  • Buyouts
  • 04 September 2023
EMEA Public to Private M&A
Change of mind: Sponsors take to de-listing their own assets

EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater

  • Investments
  • 04 September 2023
HR software solutions providers
Main Capital’s Assessio to be sold to Pollen Street

Recruitment software company tripled in revenue under Main Capital’s ownership

  • Buyouts
  • 25 August 2023
Ice cream
Exponent divests ‘significant' stake in Meadow to Canadian investor

Since 2018, GP has diversified food ingredients company's focus beyond commodity dairy

  • Exits
  • 22 August 2023

Latest News

Fund closes in US dollars
  • Funds
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote

  • 05 September 2023
Clinical trials and biotechnology
  • Buyouts
Permira to take Ergomed private for GBP 703m

Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO

  • 04 September 2023
Public sector software
  • Exits
Partners Group to release IMs for Civica sale in mid-September

Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017

  • 04 September 2023
EMEA Public to Private M&A
  • Investments
Change of mind: Sponsors take to de-listing their own assets

EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater

  • 04 September 2023
Back to Top
  • About Unquote
  • Advertise
  • Contacts
  • About Acuris
  • Terms of Use
  • Privacy Policy
  • Group Disclaimer
  • Twitter
  • LinkedIn

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013